PHAR08

Eisai and Biogen say Alzheimer's drug successfully slows cognitive decline

Eisai and Biogen say Alzheimer’s drug successfully slows cognitive decline

Sept 27 (Reuters) – Eisai Ltd (4523.T) and Biogen (BIIB.O) said on Tuesday that their experimental Alzheimer’s drug significantly slowed the disease’s massive increase in early-stage patients with the disease. Cognitive and functional decline in the trial marked a rare victory in a field littered with failed drugs. The drug, called lecanemab, slowed the progression …

Eisai and Biogen say Alzheimer’s drug successfully slows cognitive decline Read More »

EXCLUSIVE: Medical journal expands investigation into potential heart research misconduct

EXCLUSIVE: Medical journal expands investigation into potential heart research misconduct

WASHINGTON, Sept. 13 (Reuters) – Three medical journals recently launched an independent investigation into possible data manipulation in a heart study led by Temple University researchers, Reuters has learned. Misconduct investigation adds new scrutiny. The Journal of Molecular and Cellular Cardiology and the Journal of Biochemistry are investigating five papers written by Temple scientists, the …

EXCLUSIVE: Medical journal expands investigation into potential heart research misconduct Read More »

Wall Street looks to extend its winning streak ahead of CPI report

Wall Street looks to extend its winning streak ahead of CPI report

Sign up now for free unlimited access to Reuters.com register Headline CPI eased on Tuesday Bristol-Myers Squibb gains on FDA approval of psoriasis drug Twitter calls Musk’s latest attempt to cancel deal invalid Indices up: Dow 0.66%, S&P 0.97%, Nasdaq 1.14% NEW YORK, Sept 12 (Reuters) – Wall Street rallied to a two-week high on …

Wall Street looks to extend its winning streak ahead of CPI report Read More »

Top scientists join forces to study leading theory behind long-term COVID

Top scientists join forces to study leading theory behind long-term COVID

A patient with long COVID is examined at the post-coronavirus disease (COVID-19) clinic at Ichilov Hospital in Tel Aviv, Israel, on February 21, 2022. Photo taken on February 21, 2022. REUTERS/Amir Cohen/File Photo Sign up now for free and unlimited access to Reuters.com register CHICAGO, Sept 8 (Reuters) – Top scientists from leading academic centers …

Top scientists join forces to study leading theory behind long-term COVID Read More »

FDA greenlights Omicron to target COVID booster ahead of re-vaccination campaign

FDA greenlights Omicron to target COVID booster ahead of re-vaccination campaign

Sign up now for free and unlimited access to Reuters.com register Aug 31 (Reuters) – The U.S. Food and Drug Administration on Wednesday authorized Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna to update COVID-19 for major BA.4 and BA.5 Omicron sub-variants A booster as the government prepares for a broad fall vaccination campaign that could begin within …

FDA greenlights Omicron to target COVID booster ahead of re-vaccination campaign Read More »

Musk wants Twitter trial delayed after whistleblower claims

Musk wants Twitter trial delayed after whistleblower claims

Sign up now for free and unlimited access to Reuters.com register Aug 30 (Reuters) – Elon Musk is seeking to delay his trial until November, court documents show, citing his intention to pull out of a $44 billion takeover of Twitter Inc (TWTR.N) and revise his views on the lawsuit. The social media company’s complaint. …

Musk wants Twitter trial delayed after whistleblower claims Read More »